1
|
Tan XL, Vatopoulou T, Siddique A, Kolovos A, Lamb RC, Fleming C, Ferguson L, Akhras V, Jiyad Z. Cutaneous manifestations of myelodysplastic syndrome: A systematic review. Skin Health Dis 2024; 4:e323. [PMID: 38577044 PMCID: PMC10988661 DOI: 10.1002/ski2.323] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 10/12/2023] [Accepted: 11/23/2023] [Indexed: 04/06/2024]
Abstract
Myelodysplastic syndrome (MDS) may present with specific skin lesions, such as leukaemia cutis, which is a well known poor prognostic marker of leukaemia with a high risk of acute leukaemic transformation. However, less is known regarding non-specific cutaneous manifestations of MDS including the prevalence, types and their prognostic and therapeutic significance, which we aimed to determine through this systematic review. We searched electronic databases (PubMed, Medline and EMBASE) from inception up to 26 January 2023 for studies reporting cutaneous manifestations of MDS. Eighty eight articles (case reports n = 67, case series n = 21), consisting of 134 patients were identified. We identified 6 common cutaneous manifestations: neutrophilic dermatoses (n = 64), vasculitis (n = 21), granulomatous (n = 8), connective tissue disease (CTD) (n = 7; composed of dermatomyositis (n = 5), cutaneous lupus erythematosus (n = 1), and systemic sclerosis (n = 1)), panniculitis (n = 4), immunobullous (n = 1), and other (n = 29). Cutaneous features either occurred at time of MDS diagnosis in 25.3%, preceding the diagnosis in 34.7% (range 0.5-216 months), or after diagnosis in 40.0% (range 1-132 months). Prognosis was poor (40.2% death) with 34.1% progressing to acute myeloid leukaemia (AML). 50% of those with MDS who progressed to AML had neutrophilic dermatoses (p = 0.21). Myelodysplastic syndrome was fatal in 39.2% of neutrophilic dermatoses (median time from onset of cutaneous manifestation: 12 months), 50% of vasculitis (7.5 months), 62.5% of granulomatous (15.5 months) and 14.3% of CTD (7 months). Recognition of patterns of cutaneous features in MDS will improve early diagnosis and risk stratification according to subtype and associated prognosis.
Collapse
Affiliation(s)
- Xiang Li Tan
- Department of DermatologySt George's University Hospitals NHS Foundation TrustLondonUK
- St Bartholomew's HospitalBarts Health NHS TrustLondonUK
| | - Theodora Vatopoulou
- Department of HaematologySt George's University Hospitals NHS Foundation TrustLondonUK
| | | | | | - Ruth C. Lamb
- Department of DermatologySt George's University Hospitals NHS Foundation TrustLondonUK
| | - Charlotte Fleming
- Department of DermatologySt George's University Hospitals NHS Foundation TrustLondonUK
| | - Leila Ferguson
- Department of DermatologySt George's University Hospitals NHS Foundation TrustLondonUK
| | - Victoria Akhras
- Department of DermatologySt George's University Hospitals NHS Foundation TrustLondonUK
| | - Zainab Jiyad
- Department of DermatologySt George's University Hospitals NHS Foundation TrustLondonUK
- Population Health Research InstituteSt George's University of LondonLondonUK
| |
Collapse
|
2
|
Smyth P, Ferguson L, Burrows JF, Burden RE, Tracey SR, Herron ÚM, Kovaleva M, Williams R, Porter AJ, Longley DB, Barelle CJ, Scott CJ. Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy. Front Pharmacol 2023; 14:1296567. [PMID: 38116078 PMCID: PMC10728302 DOI: 10.3389/fphar.2023.1296567] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Accepted: 11/16/2023] [Indexed: 12/21/2023] Open
Abstract
Aberrant activity of the cysteine protease Cathepsin S (CTSS) has been implicated across a wide range of pathologies. Notably in cancer, CTSS has been shown to promote tumour progression, primarily through facilitating invasion and migration of tumour cells and augmenting angiogenesis. Whilst an attractive therapeutic target, more efficacious CTSS inhibitors are required. Here, we investigated the potential application of Variable New Antigen Receptors (vNARs) as a novel inhibitory strategy. A panel of potential vNAR binders were identified following a phage display panning process against human recombinant proCTSS. These were subsequently expressed, purified and binding affinity confirmed by ELISA and SPR based approaches. Selected lead clones were taken forward and were shown to inhibit CTSS activity in recombinant enzyme activity assays. Further assessment demonstrated that our lead clones functioned by a novel inhibitory mechanism, by preventing the activation of proCTSS to the mature enzyme. Moreover, using an intrabody approach, we exhibited the ability to express these clones intracellularly and inhibit CTSS activity whilst lead clones were also noted to impede cell invasion in a tumour cell invasion assay. Collectively, these findings illustrate a novel mechanistic approach for inhibiting CTSS activity, with anti-CTSS vNAR clones possessing therapeutic potential in combating deleterious CTSS activity. Furthermore, this study exemplifies the potential of vNARs in targeting intracellular proteins, opening a range of previously "undruggable" targets for biologic-based therapy.
Collapse
Affiliation(s)
- P. Smyth
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United Kingdom
| | | | - J. F. Burrows
- School of Pharmacy, Queen’s University Belfast, Belfast, United Kingdom
| | - R. E. Burden
- School of Pharmacy, Queen’s University Belfast, Belfast, United Kingdom
| | - S. R. Tracey
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United Kingdom
| | - Ú. M. Herron
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United Kingdom
| | | | - R. Williams
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United Kingdom
| | - A. J. Porter
- Elasmogen Ltd., Aberdeen, United Kingdom
- Scottish Biologics Facility, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom
| | - D. B. Longley
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United Kingdom
| | | | - C. J. Scott
- Patrick G. Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, United Kingdom
| |
Collapse
|
3
|
Brent G, Abdul-Wahab A, Borman AM, Ferguson L, Ferreras-Antolin L, Ho B, Johnson EM, Mashhoudi Y, van Rijswijk E, Wijesuriya N, Mansoor N. Disseminated Bisifusarium infection following toxic epidermal necrolysis in a child with B-cell acute lymphoblastic leukemia. Pediatr Dermatol 2022; 40:503-506. [PMID: 36334032 DOI: 10.1111/pde.15179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/21/2022] [Accepted: 10/15/2022] [Indexed: 11/07/2022]
Abstract
Fusarium is a polyphyletic genus of plant pathogens, members of which can cause opportunistic human infections with varying superficial and systemic presentations, including disseminated infections which typically occur in immunocompromised patients and have a poor prognosis. Treatment is challenging due to intrinsic resistance to many antifungal agents, and antifungal susceptibility testing is therefore essential. Early suspicion, isolation of the organism, and prompt initiation of management are crucial to improving survival. We present a case of disseminated Bisifusarium infection following toxic epidermal necrolysis in a child with B-cell acute lymphoblastic leukemia, successfully treated with liposomal amphotericin B, voriconazole, flucytosine, and terbinafine.
Collapse
Affiliation(s)
- Geoffrey Brent
- Department of Dermatology, St George's University Hospitals NHS Foundation Trust, London, UK
| | - Alya Abdul-Wahab
- Department of Dermatology, St George's University Hospitals NHS Foundation Trust, London, UK
| | - Andrew M Borman
- UK National Mycology Reference Laboratory, UK Health Security Agency (UKHSA), Bristol, UK.,Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter, UK
| | - Leila Ferguson
- Department of Dermatology, St George's University Hospitals NHS Foundation Trust, London, UK
| | - Laura Ferreras-Antolin
- Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter, UK.,Paediatric Infectious Diseases and Immunodeficiencies Unit, St George's University Hospitals NHS Foundation Trust, London, UK
| | - Bernard Ho
- Department of Dermatology, St George's University Hospitals NHS Foundation Trust, London, UK
| | - Elizabeth M Johnson
- UK National Mycology Reference Laboratory, UK Health Security Agency (UKHSA), Bristol, UK.,Medical Research Council Centre for Medical Mycology (MRC CMM), University of Exeter, Exeter, UK
| | - Yasaman Mashhoudi
- Department of Dermatology, St George's University Hospitals NHS Foundation Trust, London, UK
| | | | - Nilukshi Wijesuriya
- Department of Pathology, St George's University Hospitals NHS Foundation Trust, London, UK
| | - Nazish Mansoor
- Department of Dermatology, St George's University Hospitals NHS Foundation Trust, London, UK
| |
Collapse
|
4
|
Haq M, Reyal Y, Tiffin N, Szakacs S, Ferguson L. T-cell pseudolymphoma secondary to ixazomib for multiple myeloma. Skin Health Dis 2021; 1:e57. [PMID: 35663138 PMCID: PMC9060122 DOI: 10.1002/ski2.57] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/29/2021] [Revised: 05/24/2021] [Accepted: 05/25/2021] [Indexed: 11/13/2022]
Abstract
We present a case of a 54‐year‐old male with multiple myeloma (MM) who presented with widespread pruritic erythematous lesions following ixazomib treatment. This occurred after his third cycle of treatment with ixazomib, thalidomide and dexamethasone and was controlled by potent steroids and temporary cessation of ixazomib. The strong correlation between the timeline of the rash, ixazomib treatment and subsequent cessation led to a diagnosis of a drug‐induced rash. Skin biopsy histology, immunochemistry and the absence of monoclonal T‐cell receptor gene rearrangement further confirmed the diagnosis of a T‐cell pseudolymphoma secondary to ixazomib. Ixazomib is an oral proteasome inhibitor used in the treatment of MM. Other proteasome inhibitors have been reported to trigger cutaneous adverse effects. However, to our knowledge, this is the first report of pseudolymphoma following proteasome inhibitor use. Dermatologists should be aware of this potential effect and the possible management pathways such as cessation and dose reduction.
Collapse
Affiliation(s)
- M Haq
- Faculty of Medicine St George's, University of London London UK
| | - Y Reyal
- Department of Haematology St George's Healthcare NHS Trust London UK
| | - N Tiffin
- South West London Pathology St George's Healthcare NHS Trust London UK
| | - S Szakacs
- Department of Histopathology William Harvey Hospital, East Kent Hospitals University NHS Foundation Trust Ashford UK
| | - L Ferguson
- Department of Dermatology St George's Healthcare NHS Trust London UK
| |
Collapse
|
5
|
Froud R, Hansen SH, Ruud HK, Foss J, Ferguson L, Fredriksen PM. Relative Performance of Machine Learning and Linear Regression in Predicting Quality of Life and Academic Performance of School Children in Norway: Data Analysis of a Quasi-Experimental Study. J Med Internet Res 2021; 23:e22021. [PMID: 34009128 PMCID: PMC8325075 DOI: 10.2196/22021] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2020] [Revised: 10/26/2020] [Accepted: 05/17/2021] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND Machine learning techniques are increasingly being applied in health research. It is not clear how useful these approaches are for modeling continuous outcomes. Child quality of life is associated with parental socioeconomic status and physical activity and may be associated with aerobic fitness and strength. It is unclear whether diet or academic performance is associated with quality of life. OBJECTIVE The purpose of this study was to compare the predictive performance of machine learning techniques with that of linear regression in examining the extent to which continuous outcomes (physical activity, aerobic fitness, muscular strength, diet, and parental education) are predictive of academic performance and quality of life and whether academic performance and quality of life are associated. METHODS We modeled data from children attending 9 schools in a quasi-experimental study. We split data randomly into training and validation sets. Curvilinear, nonlinear, and heteroscedastic variables were simulated to examine the performance of machine learning techniques compared to that of linear models, with and without imputation. RESULTS We included data for 1711 children. Regression models explained 24% of academic performance variance in the real complete-case validation set, and up to 15% in quality of life. While machine learning techniques explained high proportions of variance in training sets, in validation, machine learning techniques explained approximately 0% of academic performance and 3% to 8% of quality of life. With imputation, machine learning techniques improved to 15% for academic performance. Machine learning outperformed regression for simulated nonlinear and heteroscedastic variables. The best predictors of academic performance in adjusted models were the child's mother having a master-level education (P<.001; β=1.98, 95% CI 0.25 to 3.71), increased television and computer use (P=.03; β=1.19, 95% CI 0.25 to 3.71), and dichotomized self-reported exercise (P=.001; β=2.47, 95% CI 1.08 to 3.87). For quality of life, self-reported exercise (P<.001; β=1.09, 95% CI 0.53 to 1.66) and increased television and computer use (P=.002; β=-0.95, 95% CI -1.55 to -0.36) were the best predictors. Adjusted academic performance was associated with quality of life (P=.02; β=0.12, 95% CI 0.02 to 0.22). CONCLUSIONS Linear regression was less prone to overfitting and outperformed commonly used machine learning techniques. Imputation improved the performance of machine learning, but not sufficiently to outperform regression. Machine learning techniques outperformed linear regression for modeling nonlinear and heteroscedastic relationships and may be of use in such cases. Regression with splines performed almost as well in nonlinear modeling. Lifestyle variables, including physical exercise, television and computer use, and parental education are predictive of academic performance or quality of life. Academic performance is associated with quality of life after adjusting for lifestyle variables and may offer another promising intervention target to improve quality of life in children.
Collapse
Affiliation(s)
- Robert Froud
- School of Health Sciences, Kristiania University College, Oslo, Norway.,Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, United Kingdom
| | | | | | - Jonathan Foss
- Department of Computer Science, University of Warwick, Coventry, United Kingdom
| | - Leila Ferguson
- School of Health Sciences, Kristiania University College, Oslo, Norway
| | | |
Collapse
|
6
|
Huang J, Bhargava E, Walsh M, Pennell D, Attya H, Jablenska L, Ferguson L, Lilly I, Pepper C, Tweedie D, Possamai V. 786 Retrospective analysis of paediatric ENT surgery outcomes during the COVID pandemic. Br J Surg 2021. [PMCID: PMC8135831 DOI: 10.1093/bjs/znab134.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Abstract
Introduction Studies show high morbidity/mortality for adults with peri-operative SARS-CoV-2 infection, leading to recommendations curtailing elective operations during the height of the pandemic. Our understanding of the risks associated with paediatric surgery is more limited, with preliminary data suggesting lower morbidity/mortality than in adults. A < 1% incidence of COVID-19 in paediatric patients undergoing preoperative universal screening is reported, and even in those testing positive, morbidity and mortality seem to be low. As waiting lists swell and the detriment associated with delaying surgery mounts, it is imperative to accurately quantify the risks of surgery in the paediatric population. Method Retrospective review of all paediatric ENT operations performed at the Evelina Children’s Hospital at the height of lockdown, from March to May 2020. Results 61 procedures were performed on 56 patients. 50% had a pre-operative SARS-CoV-2 nasopharyngeal swabs. All cases involved a change in anesthetic practice; 2 cases involved a change in surgical practice. We noted 2 medical complications and 1 surgical complication. All patients are currently extant. No staff or patients subsequently developed COVID. Conclusions Our perioperative infection rates and mortality/morbidity figures concord with figures published elsewhere in literature. We are cautiously optimistic regarding risks associated with paediatric ENT surgery.
Collapse
Affiliation(s)
- J Huang
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - E Bhargava
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - M Walsh
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - D Pennell
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - H Attya
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - L Jablenska
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - L Ferguson
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - I Lilly
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - C Pepper
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - D Tweedie
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| | - V Possamai
- Guy's and St Thomas's NHS Foundation Trust, London, United Kingdom
| |
Collapse
|
7
|
Ferguson L, Ho B, Weir J, Francis N, West K, Rathbone B, Larkin J, Heelan K. Extensive mucocutaneous, oesophageal and otic lichen planus secondary to nivolumab therapy. Skin Health Dis 2021; 1:e8. [PMID: 35664814 PMCID: PMC9060137 DOI: 10.1002/ski2.8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/17/2020] [Revised: 10/19/2020] [Accepted: 10/23/2020] [Indexed: 02/01/2023]
Abstract
We report a 73-year-old female with metastatic renal cell carcinoma who developed a widespread lichenoid reaction following nivolumab treatment. The timeline of the reaction strongly correlated with the nivolumab treatment and subsequent cessation. Our patient had cutaneous, mucosal, otic, ophthalmic and oesophageal involvement, demonstrating the potentially extensive nature of lichenoid reactions to anti-programmed cell death receptor-1 (anti-PD1) therapies. Although lichenoid reactions to anti-PD1 therapies are now well recognized, there have been no previous reports of otic or oesophageal involvement in the literature. Although cutaneous lichenoid reactions do not tend to be severe or treatment limiting, more widespread systemic lichenoid reactions are challenging to manage, particularly in the context of malignancy. This very unusual case highlights the importance of considering involvement beyond the skin in all lichenoid skin reactions.
Collapse
Affiliation(s)
| | - B. Ho
- Dermatology DepartmentSt George's University Hospitals NHS Foundation TrustLondonUK
| | - J. Weir
- Department of HistopathologyImperial College Healthcare NHS TrustLondonUK
| | - N. Francis
- Department of HistopathologyImperial College Healthcare NHS TrustLondonUK
| | - K. West
- Histopathology DepartmentLeicester Royal InfirmaryLeicesterUK
| | - B. Rathbone
- Gastroenterology DepartmentLeicester Royal InfirmaryLeicesterUK
| | - J. Larkin
- Royal Marsden Hospital NHS TrustLondonUK
| | - K. Heelan
- Royal Marsden Hospital NHS TrustLondonUK
| |
Collapse
|
8
|
Cato-Addison WB, Ferguson L, Strachan RD, Clark R, Murray JS, Moore I. Intra-dialytic intracranial pressure monitoring in a patient with lumbo-peritoneal shunt for idiopathic intracranial hypertension. Br J Neurosurg 2020:1-3. [DOI: 10.1080/02688697.2020.1774509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- W. B. Cato-Addison
- Department of Neurosurgery, James Cook University Hospital, Middlesbrough, UK
| | - L. Ferguson
- Department of Neurosurgery, Royal Victoria Infirmary, Newcastle Upon Tyne, UK
| | - R. D. Strachan
- Department of Neurosurgery, James Cook University Hospital, Middlesbrough, UK
| | - R. Clark
- Renal Unit, James Cook University Hospital, Middlesbrough, UK
| | - J. S. Murray
- Renal Unit, James Cook University Hospital, Middlesbrough, UK
| | - I. Moore
- Renal Unit, James Cook University Hospital, Middlesbrough, UK
| |
Collapse
|
9
|
De Brito M, Ferguson L, Mansour S, Khan I. An unusual manifestation of X‐linked hypohidrotic ectodermal dysplasia with palmoplantar keratoderma. Clin Exp Dermatol 2020; 45:352-353. [DOI: 10.1111/ced.14096] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Accepted: 09/11/2019] [Indexed: 11/30/2022]
Affiliation(s)
- M. De Brito
- Department of Dermatology St George’s Healthcare NHS Trust London UK
| | - L. Ferguson
- Department of Dermatology St George’s Healthcare NHS Trust London UK
| | - S. Mansour
- St George’s Healthcare NHS Trust St George’s, University of London London UK
| | - I. Khan
- Department of Dermatology St George’s Healthcare NHS Trust London UK
| |
Collapse
|
10
|
Coleman KA, Boscan P, Ferguson L, Twedt D, Monnet E. Evaluation of gastric motility in nine dogs before and after prophylactic laparoscopic gastropexy: a pilot study. Aust Vet J 2019; 97:225-230. [PMID: 31236930 DOI: 10.1111/avj.12829] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2018] [Revised: 03/22/2019] [Accepted: 04/07/2019] [Indexed: 11/28/2022]
Abstract
BACKGROUND The purpose of this study was to evaluate the effect of a prophylactic laparoscopic gastropexy on gastric motility in healthy large-breed dogs. METHODS This was a prospective pilot study with nine healthy client-owned dogs. Each dog was its own control. Gastric motility was evaluated before and after laparoscopic gastropexy. Dogs were fed a standard diet three weeks before and after surgery. Gastric motility was measured before and 3 weeks after surgery. A wireless motility capsule (WMC) was used to measure gastric pH, intragastric pressure, temperature, frequency of contractions, motility index (MI) and transit time. Non-parametric statistical analysis was used to compare the paired data. Clients were contacted for follow-up information 2 years postoperatively. RESULTS Median frequency of gastric contractions was 1.3 (range, 0.6-1.9 contractions/min) before gastropexy and 1.0 (range, 0.3-2.6 contractions/min) after gastropexy (P = 0.820). Median MI was 49.2 (range, 23.7-96.6) before gastropexy and 28.1 (range, 12.2-148.9) after gastropexy (P = 0.652). Median gastric emptying time was 1140 (range, 486-1230 min) before gastropexy and 1110 (range, 306-2610 min) after gastropexy (P = 0.570). During the hour before the WMC passed through the pylorus, median MI was 72.2 (range, 48.2-549.3) before gastropexy and 52.9 (range, 15.20-322.8) after gastropexy (P = 0.734), and frequency of contractions was 1.1 (range, 0.9-4.1 contractions/min) before gastropexy and 1.2 (range, 0.5-3.0 contractions/min) after gastropexy (P = 0.652). CONCLUSION Motility in the stomach did not change in healthy dogs after prophylactic laparoscopic gastropexy. We conclude that preventive laparoscopic gastropexy does not induce gastroparesis.
Collapse
Affiliation(s)
- K A Coleman
- Department of Clinical Sciences, Colorado State University Veterinary Teaching Hospital, 300 West Drake Road, Fort Collins, CO 80523, USA
| | - P Boscan
- Department of Clinical Sciences, Colorado State University Veterinary Teaching Hospital, 300 West Drake Road, Fort Collins, CO 80523, USA
| | - L Ferguson
- Department of Clinical Sciences, Colorado State University Veterinary Teaching Hospital, 300 West Drake Road, Fort Collins, CO 80523, USA
| | - D Twedt
- Department of Clinical Sciences, Colorado State University Veterinary Teaching Hospital, 300 West Drake Road, Fort Collins, CO 80523, USA
| | - E Monnet
- Department of Clinical Sciences, Colorado State University Veterinary Teaching Hospital, 300 West Drake Road, Fort Collins, CO 80523, USA
| |
Collapse
|
11
|
García-Ruiz NS, Nejad B, Wilson M, Ferguson L. 2485 Identifying Barriers for Same-Day Discharge of Minimally Invasive Hysterectomies. J Minim Invasive Gynecol 2019. [DOI: 10.1016/j.jmig.2019.09.250] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
12
|
Greco T, Ferguson L, Giza C, Prins ML. Mechanisms underlying vulnerabilities after repeat mild traumatic brain injuries. Exp Neurol 2019; 317:206-213. [PMID: 30853388 DOI: 10.1016/j.expneurol.2019.01.012] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2018] [Revised: 01/17/2019] [Accepted: 01/20/2019] [Indexed: 11/16/2022]
Abstract
Traumatic brain injury (TBI) has drawn national attention for its high incidence and mechanistic complexity. The majority of TBI cases are "mild" in nature including concussions and mild TBI (mTBI). Concussions are a distinct form of mTBI where diagnosis is difficult, quantification of the incidence is challenging and there is greater risk for subsequent injuries. While concussions occur in the general population, it has become a hallmark injury consistently observed among adolescent and young adult athletes and the risks for repeat TBI (rTBI) is significant. Clinical and experimental evidence shows that the magnitude and duration of deficits is dependent on the number and the interval between injuries. Several studies suggest that metabolic vulnerabilities after injury may contribute to the window for cerebral vulnerability from rTBI. In addition to metabolism, this review addresses how age, sex and hormones also play an important role in the response to repeat concussions. Understanding how these factors collectively contribute to concussion and rTBI recovery is critically important in establishing age/sex appropriate return to play guidelines, injury prevention, therapeutic interventions and mitigation of long-term consequences of rTBI.
Collapse
Affiliation(s)
- T Greco
- UCLA Department of Neurosurgery, 300 Stein Plaza, Los Angeles, CA 90095, United States
| | - L Ferguson
- UCLA Department of Neurosurgery, 300 Stein Plaza, Los Angeles, CA 90095, United States
| | - C Giza
- UCLA Department of Neurosurgery, 300 Stein Plaza, Los Angeles, CA 90095, United States
| | - M L Prins
- UCLA Department of Neurosurgery, 300 Stein Plaza, Los Angeles, CA 90095, United States.
| |
Collapse
|
13
|
Malone V, Ezard N, Hodge S, Ferguson L, Schembri A, Bonevski B. Nurse provision of support to help inpatients quit smoking. Health Promot J Austr 2019; 28:251-254. [PMID: 28002718 DOI: 10.1071/he16082] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2016] [Accepted: 10/13/2016] [Indexed: 11/23/2022] Open
Abstract
Issue addressed Identification of the factors that facilitate nurses to provide smoking cessation advice to hospitalised patients. Method Six semistructured focus groups with 26 nurses were conducted in June 2015. Participants completed a structured survey to collect patient demographic data and assess attitudes towards their role in addressing smoking cessation among inpatients. Results Important themes that emerged from the qualitative data were: nurses' negative perceptions of smokers, nurses' confidence in their knowledge of smoking cessation care and nurses' uncertainty around whose role it is to provide smoking cessation care. Conclusion Nurses require training in order to confidently and competently address smoking among inpatients as part of routine care. Formal ways to document the smoking status of inpatients and the offer of smoking cessation support from a nurse to an inpatient would enhance the communication between nurses around which inpatients had been asked about their smoking status and which had not. For patients who are resistant to conventional cessation strategies, innovative ways are needed to reduce the harm caused to them by tobacco use. So what? Nurses need to be provided with education and training around smoking cessation to increase their confidence and skills to provide smoking cessation care to inpatients.
Collapse
Affiliation(s)
- V Malone
- Level 2, The O'Brien Centre, St Vincent's Hospital, 390 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
| | - N Ezard
- Level 2, The O'Brien Centre, St Vincent's Hospital, 390 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
| | - S Hodge
- Network of Alcohol and Other Drugs Agencies, PO Box 2345, Strawberry Hills, NSW 2012, Australia
| | - L Ferguson
- Level 2, The O'Brien Centre, St Vincent's Hospital, 390 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
| | - A Schembri
- Level 2, The O'Brien Centre, St Vincent's Hospital, 390 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
| | - B Bonevski
- University of Newcastle, 5014 Level 5, McAuley Centre, Calvary Mater Hospital, Edith Street, Waratah, NSW 2298, Australia
| |
Collapse
|
14
|
Abstract
BACKGROUND Eczema is a common, chronic, inflammatory skin condition that is frequently associated with atopic conditions, including asthma. Leukotriene receptor antagonists (LTRAs) have a corticosteroid-sparing role in asthma, but their role in eczema remains controversial. Currently available topical therapies for eczema are often poorly tolerated, and use of systemic agents is restricted by their adverse effect profile. A review of alternative treatments was therefore warranted. OBJECTIVES To assess the possible benefits and harms of leukotriene receptor antagonists for eczema. SEARCH METHODS We searched the following databases to September 2017: the Cochrane Skin Specialised Register, CENTRAL, MEDLINE, Embase, and the GREAT database. We also searched five trial registries, and handsearched the bibliographies of all extracted studies for further relevant trials. SELECTION CRITERIA Randomised controlled trials of LTRAs alone or in combination with other (topical or systemic) treatments compared with other treatments alone such as topical corticosteroids or placebo for eczema in the acute or chronic (maintenance) phase of eczema in adults and children. DATA COLLECTION AND ANALYSIS We used the standard methodological procedures expected by Cochrane. The primary outcome measures were change in disease severity, long-term symptom control, and adverse effects of treatment. Secondary outcomes were change in corticosteroid requirement, reduction of pruritis, quality of life, and emollient requirement. We used GRADE to assess the quality of the evidence for each outcome. MAIN RESULTS Only five studies (including a total of 202 participants) met the inclusion criteria, all of which assessed oral montelukast; hence, we found no studies assessing other LTRAs. Treatment ranged from four to eight weeks, and outcomes were assessed at the end of treatment; therefore, we could only report short-term measurements (defined as less than three months follow-up from baseline). Montelukast dosing was 10 mg for adults (age 14 years and above) and 5 mg for children (age 6 years to 14 years). One study included children (aged 6 years and above) among their participants, while the remaining studies only included adults (participant age ranged from 16 to 70 years). The participants were diagnosed with moderate-to-severe eczema in four studies and moderate eczema in one study. The study setting was unclear in two studies, multicentre in two studies, and single centre in one study; the studies were conducted in Europe and Bangladesh. Two studies were industry funded. The comparator was placebo in three studies and conventional treatment in two studies. The conventional treatment comparator was a combination of antihistamines and topical corticosteroids (plus oral antibiotics in one study).Four of the studies did not adequately describe their randomisation or allocation concealment method and were considered as at unclear risk of selection bias. Only one study was at low risk of performance and detection bias. However, we judged all studies to be at low risk of attrition and reporting bias.We found no evidence of a difference in disease severity of moderate-to-severe eczema after short-term use of montelukast (10 mg) when compared with placebo. The outcome was assessed using the modified EASI (Eczema Area and Severity Index) score and SASSAD (Six Area, Six Sign Atopic Dermatitis) severity score (standardised mean difference 0.29, with a positive score showing montelukast is favoured, 95% confidence interval (CI) -0.23 to 0.81; 3 studies; n = 131; low-quality evidence).When short-term montelukast (10 mg) treatment was compared with conventional treatment in one study, the mean improvement in severity of moderate-to-severe eczema was greater in the intervention group (measured using SCORAD (SCORing of Atopic Dermatitis) severity index) (mean difference 10.57, 95% CI 4.58 to 16.56; n = 31); however, another study of 32 participants found no significant difference between groups using the same measure (mean improvement was 25.2 points with montelukast versus 23.9 points with conventional treatment; no further numerical data provided). We judged the quality of the evidence as very low for this outcome, meaning the results are uncertain.All studies reported their adverse event rate during treatment. Four studies (136 participants) reported no adverse events. In one study of 58 participants with moderate eczema who received montelukast 10 mg (compared with placebo), there was one case of septicaemia and one case of dizziness reported in the intervention group, both resulting in study withdrawal, although whether these effects were related to the medication is unclear. Mild side effects (e.g. headache and mild gastrointestinal disturbances) were also noted, but these were fairly evenly distributed between the montelukast and placebo groups. The quality of evidence for this outcome was low.No studies specifically evaluated emollient requirement or quality of life. One study that administered treatment for eight weeks specifically evaluated pruritus improvement at the end treatment and topical corticosteroid use during treatment. We found no evidence of a difference between montelukast (10 mg) and placebo for both outcomes (low-quality evidence, n = 58). No other study assessed these outcomes. AUTHORS' CONCLUSIONS The findings of this review are limited to montelukast. There was a lack of evidence addressing the review question, and the quality of the available evidence for most of the measured outcomes was low. Some primary and secondary outcomes were not addressed at all, including long-term control.We found no evidence of a difference between montelukast (10 mg) and placebo on disease severity, pruritus improvement, and topical corticosteroid use. Very low-quality evidence means we are uncertain of the effect of montelukast (10 mg) compared with conventional treatment on disease severity. Participants in only one study reported adverse events, which were mainly mild (low-quality evidence).There is no evidence that LTRA is an effective treatment for eczema. Serious limitations were that all studies focused on montelukast and only included people with moderate-to-severe eczema, who were mainly adults; and that each outcome was evaluated with a small sample size, if at all.Further large randomised controlled trials, with a longer treatment duration, of adults and children who have eczema of all severities may help to evaluate the effect of all types of LTRA, especially on eczema maintenance.
Collapse
Affiliation(s)
- Leila Ferguson
- St Helier HospitalDepartment of DermatologyWrythe LaneCarshaltonSurreyUKSM5 1AA
| | - Masaki Futamura
- Nagoya Medical CenterDepartment of Pediatrics4‐1‐1 SannomaruNaka‐kuNagoyaJapan460‐0001
| | - Efstratios Vakirlis
- Aristotle University Medical SchoolA' Department of DermatologyKanari 13ThessalonikiGreece54644
| | - Reiji Kojima
- School of Medicine, University of YamanashiDepartment of Health SciencesYamanashiJapan
| | - Hatoko Sasaki
- National Center for Child Health and DevelopmentDepartment of Health Policy2‐10‐1 Okura, SetagayaTokyoTokyoJapan157‐8535
| | - Amanda Roberts
- Nottingham Support Group for Carers of Children with EczemaNottinghamUKNG5 4FG
| | - Rintaro Mori
- National Center for Child Health and DevelopmentDepartment of Health Policy2‐10‐1 Okura, SetagayaTokyoTokyoJapan157‐8535
| | | |
Collapse
|
15
|
Affiliation(s)
- L. Ferguson
- Dermatology Department Chelsea and Westminster Hospital London UK
| | - L. Fearfield
- Dermatology Department Chelsea and Westminster Hospital London UK
| |
Collapse
|
16
|
Ferguson L, Fearfield L. Paraneoplastic pemphigus foliaceus related to underlying breast cancer. Clin Exp Dermatol 2018; 43:817-818. [PMID: 29770472 DOI: 10.1111/ced.13602] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/01/2017] [Indexed: 11/29/2022]
Affiliation(s)
- L Ferguson
- Department of Dermatology, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK
| | - L Fearfield
- Department of Dermatology, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK
| |
Collapse
|
17
|
Palmer J, Patel T, Eldredge-Hindy H, Keith S, Patel T, Malatesta T, DiNome J, Lowther A, Ferguson L, Wagenborg S, Smyles J, Babaria U, Stabile R, Gressen E, Rudoler S, Fisher S. EP-1675: Patients undergoing radiation therapy at risk for financial toxicity: A prospective survey study. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31984-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
18
|
Abstract
Tinea capitis is the most important superficial fungal condition in children. It is often unrecognised but the presence of alopecia, scale and lymphadenopathy, especially in inner-city children should prompt investigation. An understanding of changing epidemiology and prevalence of causative organisms is important in deciding appropriate therapy. The use of diagnostic aids including dermoscopy is increasing and is reported to be helpful in identifying subtle signs. Trichophyton tonsurans accounts for the majority of cases in the UK and terbinafine is increasingly advocated as a safe and effective therapy. Exclusion from school is unnecessary provided the child is receiving appropriate systemic and topical therapy, but family members should be screened and carriers should receive treatment. Steroids and surgical treatments should be avoided. Treatment failure is common and may be multifactorial. Mycological cure after completing treatment should be sought and therefore follow up is necessary for Tinea capitis cases. Development of molecular diagnostic methods may improve our ability to diagnose Tinea capitis accurately and quickly in the future. Emerging new dermatophytoses affecting other anatomical sites are discussed which, although not common in the UK, may be seen due to increasing travel worldwide.
Collapse
Affiliation(s)
- Leila Ferguson
- Department of Dermatology, Chelsea and Westminster Hospital, Fulham Road, London, SW10 9NH, UK.
| | - L Claire Fuller
- Department of Dermatology, Chelsea and Westminster Hospital, Fulham Road, London, SW10 9NH, UK.
| |
Collapse
|
19
|
Ferguson L, Chong H, Singh M. Ecthyma gangrenosum without bacteraemia: evidence in favour of a broader definition. Clin Exp Dermatol 2017; 42:324-327. [PMID: 28239902 DOI: 10.1111/ced.13064] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/01/2016] [Indexed: 11/29/2022]
Abstract
Ecthyma gangrenosum (EG) is often defined as a cutaneous manifestation of Pseudomonas aeruginosa septicaemia, typically secondary to neutropenia. There is increasing recognition that a broader definition is warranted, as numerous causative organisms and predisposing conditions have been reported. We describe two cases of EG that occurred without bacteraemia. In this atypical subset of cases, the skin is thought to represent the primary inoculation site from which haematogenous spread can occur. The first case occurred in the context of human immunodeficiency virus (HIV) infection, a rarely reported association. The evidence base guiding clinicians on management of EG is very limited, particularly in relation to patients with HIV, in whom recurrence risk may be higher than normal. Recurrent EG is described in our second case, in an individual with Good syndrome, a rare association of thymoma and immunodeficiency.
Collapse
Affiliation(s)
- L Ferguson
- Department of Dermatology, St George's Hospital, London, UK
| | - H Chong
- Department of Cellular Pathology, St George's Hospital, London, UK
| | - M Singh
- Department of Dermatology, St George's Hospital, London, UK
| |
Collapse
|
20
|
Ferguson L, MacAndie C. From the bathroom to the bone-anchored hearing aid: an idea on how to remove a stripped abutment screw from a bone-anchored hearing aid. Clin Otolaryngol 2015; 41:620-1. [PMID: 26585704 DOI: 10.1111/coa.12446] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/15/2015] [Indexed: 11/28/2022]
Affiliation(s)
- L Ferguson
- Department of Otolaryngology and Head and Neck Surgery, Royal Alexandra Hospital, Paisley, UK.
| | - C MacAndie
- Department of Otolaryngology and Head and Neck Surgery, Royal Alexandra Hospital, Paisley, UK
| |
Collapse
|
21
|
Ferguson L, Patel S, Holden C. Pachydermodactyly. Assoc Med J 2015. [DOI: 10.1136/bmj.h2889] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
22
|
De Rita F, Hasan A, Haynes S, Peng E, Gandolfo F, Ferguson L, Kirk R, Smith J, Griselli M. Outcome of mechanical cardiac support in children using more than one modality as a bridge to heart transplantation. Eur J Cardiothorac Surg 2015; 48:917-22; discussion 922. [DOI: 10.1093/ejcts/ezu544] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2014] [Accepted: 12/15/2014] [Indexed: 11/13/2022] Open
|
23
|
de Rita F, Gandolfo F, Haynes S, Kirk R, Ferguson L, Smith JH, Hasan A, Griselli M. 279 * OUTCOME OF MECHANICAL CARDIAC SUPPORT IN CHILDREN USING MORE THAN ONE MODALITY AS BRIDGE TO HEART TRANSPLANTATION. Interact Cardiovasc Thorac Surg 2014. [DOI: 10.1093/icvts/ivu276.279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Ferguson L, Murphy GH. The effects of training on the ability of adults with an intellectual disability to give informed consent to medication. J Intellect Disabil Res 2014; 58:864-873. [PMID: 24341991 DOI: 10.1111/jir.12101] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 10/29/2013] [Indexed: 06/03/2023]
Abstract
BACKGROUND This study had two aims: to investigate the capacity of individuals with intellectual disabilities (ID) to make decisions about their medications, and to evaluate whether the provision of training (information) sessions on medications would increase their capacity. METHOD Twenty-eight adults (18 male and 10 female), with a mild to moderate ID were included in this study and they were taking either Epilim, Metformin or Haloperidol medications. The participants were split into groups that comprised of participants taking the same medications. Each of the groups received three training sessions on their own medications. Capacity to consent was measured by the Adapted - Assessment of Capacity Questionnaire (A-ACQ), which was specially adapted for each medication type from the original measure (ACQ). Receptive language ability was measured by the British Picture Vocabulary Scale-II (BPVS-II). RESULTS A two-factor mixed anova analysis indicated that the provision of training had improved the capacity of the participants to give informed consent to taking their medications. Analysis using Pearson's correlations indicated that increased levels of receptive language ability correlated with greater ability to give informed consent to taking medication. CONCLUSIONS The provision of information that is formatted in a way that individuals with ID can understand may be a useful way to increase knowledge on medications. Further research that investigates the provision of information with larger samples is warranted.
Collapse
Affiliation(s)
- L Ferguson
- Institute for Health Research, University of Lancaster, Lancaster, UK
| | | |
Collapse
|
25
|
Futamura M, Ferguson L, Vakirlis E, Kojima R, Roberts A, Mori R. Leukotriene receptor antagonists for atopic eczema. Cochrane Database of Systematic Reviews 2014. [DOI: 10.1002/14651858.cd011224] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Masaki Futamura
- National Center for Child Health and Development; Department of Medical Specialities, Division of Allergy; 2-10-1 Okura, Setagaya-ku Tokyo Japan 157-8535
| | - Leila Ferguson
- St Helier Hospital; Department of Dermatology; Wrythe Lane Carshalton Surrey UK SM5 1AA
| | - Efstratios Vakirlis
- Aristotle University of Thessaloniki; A' Department of Dermatology and Venereology; Kanari 13 Thessaloniki Greece 54644
| | - Reiji Kojima
- National Center for Child Health and Development; Department of Allergy & Immunology; Tokyo Japan
| | - Amanda Roberts
- Nottingham Support Group for Carers of Children with Eczema; Nottingham UK NG5 4FG
| | - Rintaro Mori
- National Center for Child Health and Development; Department of Health Policy; 2-10-1 Okura Setagaya-ku Tokyo Tokyo Japan 166-0014
| |
Collapse
|
26
|
Njai H, Shimakawa Y, Ferguson L, Sanneh B, Dalessandro U, Mendy M, Thursz M, Njie R, Lemoine M. Validation of hepatitis B surface antigen (HBsAg) rapid test to screen HBV infection in rural Gambia. Int J Infect Dis 2014. [DOI: 10.1016/j.ijid.2014.03.984] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
27
|
Grove JR, Main LC, Partridge K, Bishop DJ, Russell S, Shepherdson A, Ferguson L. Training distress and performance readiness: laboratory and field validation of a brief self-report measure. Scand J Med Sci Sports 2014; 24:e483-490. [PMID: 24646366 DOI: 10.1111/sms.12214] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/15/2014] [Indexed: 11/28/2022]
Abstract
Three studies were conducted to validate the Training Distress Scale (TDS), a 19-item measure of training-related distress and performance readiness. Study 1 was a randomized, controlled laboratory experiment in which a treatment group undertook daily interval training until a 25% decrement occurred in time-to-fatigue performance. Comparisons with a control group showed that TDS scores increased over time within the treatment group but not in the control group. Study 2 was a randomized, controlled field investigation in which performance capabilities and TDS responses were compared across a high-intensity interval training group and a control group that continued normal training. Running performance decreased significantly in the training group but not in the control group, and scores on the TDS mirrored those changes in performance capabilities. Study 3 examined the relationship between TDS scores obtained over a 2-week period before major swimming competitions and subsequent performance in those competitions. Significantly, better performance was observed for swimmers with low TDS scores compared with those with moderate or high TDS scores. These findings provide both laboratory and field evidence for the validity of the TDS as a measure of short-term training distress and performance readiness.
Collapse
Affiliation(s)
- J R Grove
- School of Sport Science, Exercise & Health, The University of Western Australia, Crawley, Western Australia, Australia
| | | | | | | | | | | | | |
Collapse
|
28
|
Sanden B, Ferguson L, Corwin D. DEVELOPMENT AND LONG-TERM SALT TOLERANCE OF PISTACHIOS FROM PLANTING TO MATURITY USING SALINE GROUNDWATER. ACTA ACUST UNITED AC 2014. [DOI: 10.17660/actahortic.2014.1028.53] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
29
|
De Rita F, Hasan A, Haynes S, Crossland D, Kirk R, Ferguson L, Peng E, Griselli M. Mechanical cardiac support in children with congenital heart disease with intention to bridge to heart transplantation. Eur J Cardiothorac Surg 2014; 46:656-62; discussion 662. [DOI: 10.1093/ejcts/ezu039] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
30
|
Borthwick D, Smith A, McPhelim J, Byers J, Devlin J, Docherty K, Jones K, Ferguson L. 106 The patient experience of lung cancer in Scotland. Lung Cancer 2014. [DOI: 10.1016/s0169-5002(14)70106-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
31
|
Cassidy J, Wagh A, Haynes S, Kirk R, Ferguson L, Smith J, Guillen M, Thiru Y, Griselli M, Hasan A. 337 Mechanical Circulatory Support (MCS) as a Bridge to Paediatric Heart Transplant: Does the End Justify the Means? J Heart Lung Transplant 2012. [DOI: 10.1016/j.healun.2012.01.346] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
32
|
Cassidy J, Ferguson L, Guillen M, Haynes S, Smith J, Thiru Y, Kirk R, Kesteven P, Griselli M, Hasan A. 821 Heparin Free VADs: Can It Be Done? J Heart Lung Transplant 2012. [DOI: 10.1016/j.healun.2012.01.838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
33
|
Eaton DJ, Barber E, Ferguson L, Mark Simpson G, Collis CH. Radiotherapy treatment of keloid scars with a kilovoltage X-ray parallel pair. Radiother Oncol 2011; 102:421-3. [PMID: 21889225 DOI: 10.1016/j.radonc.2011.08.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2011] [Revised: 08/01/2011] [Accepted: 08/05/2011] [Indexed: 11/18/2022]
Abstract
An established treatment for keloids is surgery and radiotherapy, using a single applied field. However, earlobe keloids lend themselves to a parallel opposed pair approach. Delivery with a superficial X-ray unit is practicable and improves homogeneity within the treatment volume. It has been implemented in this centre since 2007.
Collapse
Affiliation(s)
- David J Eaton
- Radiotherapy Department, Royal Free Hospital, London, UK.
| | | | | | | | | |
Collapse
|
34
|
Fan M, Ferguson L, Rohan L, Meyn L, Hillier S. P2-S9.06 Vaginal film microbicides for HIV prevention: a mixed methods study of women's preferences. Sex Transm Infect 2011. [DOI: 10.1136/sextrans-2011-050108.392] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
35
|
Ferguson L, Bradshaw R, Wolstenholme R, Clench M, Francese S. Two-Step Matrix Application for the Enhancement and Imaging of Latent Fingermarks. Anal Chem 2011; 83:5585-91. [DOI: 10.1021/ac200619f] [Citation(s) in RCA: 68] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- L. Ferguson
- Biomedical Research Centre, Sheffield Hallam University, Howard Street S1 1WB, Sheffield, United Kingdom
| | - R. Bradshaw
- Biomedical Research Centre, Sheffield Hallam University, Howard Street S1 1WB, Sheffield, United Kingdom
| | - R. Wolstenholme
- Biomedical Research Centre, Sheffield Hallam University, Howard Street S1 1WB, Sheffield, United Kingdom
| | - M. Clench
- Biomedical Research Centre, Sheffield Hallam University, Howard Street S1 1WB, Sheffield, United Kingdom
| | - S. Francese
- Biomedical Research Centre, Sheffield Hallam University, Howard Street S1 1WB, Sheffield, United Kingdom
| |
Collapse
|
36
|
Ferguson L, Vasani S, Sandhu G. The use of lesion localization needles in tracheal resections. Clin Otolaryngol 2011; 36:187. [PMID: 21518286 DOI: 10.1111/j.1749-4486.2011.02268.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
37
|
Irving C, Parry G, Crossland D, Cassidy J, Ferguson L, Guillen M, Thiru Y, Hasan A, Griselli M, Kirk R. 262 Experience with ABO-Incompatible Cardiac Transplantation in Sensitised Patients. J Heart Lung Transplant 2011. [DOI: 10.1016/j.healun.2011.01.269] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
38
|
Cassidy J, Kirk R, Haynes S, Ferguson L, Guillen M, Thiru Y, Hayden-Smith J, Chaudhari M, Griselli M, Hasan A. 329 Mechanical Circulatory Support (MCS) as a Bridge To Transplant in Children with Univentricular Physiology: What Have We Learned? J Heart Lung Transplant 2011. [DOI: 10.1016/j.healun.2011.01.336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
39
|
Ferguson L, Chipp E, Rayatt S. Gravitational retrograde venous perfusion - a technique for limb extremity salvage when microvascular arterial repair is not possible. J Plast Reconstr Aesthet Surg 2010; 63:e422-3. [DOI: 10.1016/j.bjps.2009.10.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/09/2009] [Accepted: 10/21/2009] [Indexed: 11/16/2022]
|
40
|
|
41
|
Tibby S, Durward A, Ferguson L, Bangalore H, Murdoch I. Relationship between effective osmolality changes and neurological status during treatment for severe paediatric diabetic ketoacidosis. Crit Care 2009. [PMCID: PMC4083999 DOI: 10.1186/cc7277] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
|
42
|
Langley J, Frenette L, Ferguson L, Riff D, Folkerth S, Sheldon E, Segall N, Risi G, Middleton R, Johnson C, Li P, Innis B, Fries L. Safety and Cross-Reactive Immunogenicity of Two H5N1 A/Indonesia/5/2005 (Clade 2.1) AS-Adjuvanted Prepandemic Candidate Influenza Vaccines: A Phase I/II Clinical Trial. Int J Infect Dis 2008. [DOI: 10.1016/j.ijid.2008.05.365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
43
|
Bailey FA, Ferguson L, Williams BR, Woodby LL, Redden DT, Durham RM, Goode PS, Burgio KL. Palliative Care Intervention for Choice and Use of Opioids in the Last Hours of Life. J Gerontol A Biol Sci Med Sci 2008; 63:974-8. [DOI: 10.1093/gerona/63.9.974] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
44
|
Ferguson L, Oden M, Kaye K, Engemann J, McDonald J, Trofi W. Reprocessing disposable single-use devices: From skepticism to success. Am J Infect Control 2005. [DOI: 10.1016/j.ajic.2005.04.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
45
|
Goodacre S, Helgason A, Nicholson J, Southam L, Ferguson L, Hickey E, Vega E, Stefánsson K, Ward R, Sykes B. Genetic evidence for a family-based Scandinavian settlement of Shetland and Orkney during the Viking periods. Heredity (Edinb) 2005; 95:129-35. [PMID: 15815712 DOI: 10.1038/sj.hdy.6800661] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
The Viking age witnessed the expansion of Scandinavian invaders across much of northwestern Europe. While Scandinavian settlements had an enduring cultural impact on North Atlantic populations, the nature and extent of their genetic legacy in places such as Shetland and Orkney is not clear. In order to explore this question further, we have made an extensive survey of both Y-chromosomal and mitochondrial DNA (mtDNA) variation in the North Atlantic region. Our findings indicate an overall Scandinavian ancestry of approximately 44% for Shetland and approximately 30% for Orkney, with approximately equal contributions from Scandinavian male and female subjects in both cases. This contrasts with the situation for the Western Isles, where the overall Scandinavian ancestry is less ( approximately 15%) and where there is a disproportionately high contribution from Scandinavian males. In line with previous studies, we find that Iceland exhibits both the greatest overall amount of Scandinavian ancestry (55%) and the greatest discrepancy between Scandinavian male and female components. Our results suggest that while areas close to Scandinavia, such as Orkney and Shetland, may have been settled primarily by Scandinavian family groups, lone Scandinavian males, who later established families with female subjects from the British Isles, may have been prominent in areas more distant from their homeland.
Collapse
Affiliation(s)
- S Goodacre
- Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Epstein L, Beede R, Kaur S, Ferguson L. Rootstock Effects on Pistachio Trees Grown in Verticillium dahliae-Infested Soil. Phytopathology 2004; 94:388-395. [PMID: 18944115 DOI: 10.1094/phyto.2004.94.4.388] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
ABSTRACT In a field trial in soil infested with Verticillium dahliae, we compared the yield, growth, incidence of symptoms of Verticillium wilt, and mortality of two interspecific hybrid pistachio tree rootstocks (UCBI and PGII) with the standard rootstocks: the V. dahliae-resistant and susceptible Pistacia integerrima and P. atlantica, respectively. After 10 years, the trees were destructively sampled for V. dahliae in the xylem at the graft union. The results indicate that trees on the (P. atlantica 'KAC' x P. integerrima) hybrid UCBI rootstock grew and yielded as well as those on P. integerrima. Trees on the hybrid PGII yielded the least. Analysis of variance and log-linear models indicate that in soil infested with V. dahliae, three associations significantly affect pistachio nut yield. Rootstock affects scion vigor and extent of infection. Third, the extent of infection and scion vigor are inversely associated. Although trees on the P. integerrima rootstock had the highest ratings in a visual assessment of vigor, 65% were infected with V. dahliae in the trunk in the graft region compared with 73% in P. atlantica and 25% in UCBI. Thus, P. integerrima and UCBI have at least one different mechanism for resistance to V. dahliae.
Collapse
|
47
|
Firrincieli V, Geldmaker B, Custis N, Ehrensberger R, Erwin E, Riposo D, Shufflebarger C, Ferguson L, Platts-Mills T. Risk factors for asthma among head start children: Evaluation of physical activity and allergy. J Allergy Clin Immunol 2003. [DOI: 10.1016/s0091-6749(03)80675-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
48
|
Tibby S, West J, Ferguson L, Durward A, Murdoch I. Crit Care 2003; 7:P246. [DOI: 10.1186/cc2135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
49
|
Goumon Y, Casares F, Pryor S, Ferguson L, Brownawell B, Cadet P, Rialas CM, Welters ID, Sonetti D, Stefano GB. Ascaris suum, an intestinal parasite, produces morphine. J Immunol 2000; 165:339-43. [PMID: 10861070 DOI: 10.4049/jimmunol.165.1.339] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
The parasitic worm Ascaris suum contains the opiate alkaloid morphine as determined by HPLC coupled to electrochemical detection and by gas chromatography/mass spectrometry. The level of this material is 1168 +/- 278 ng/g worm wet weight. Furthermore, Ascaris maintained for 5 days contained a significant amount of morphine, as did their medium, demonstrating their ability to synthesize the opiate alkaloid. To determine whether the morphine was active, we exposed human monocytes to the material, and they immediately released nitric oxide in a naloxone-reversible manner. The anatomic distribution of morphine immunoreactivity reveals that the material is in the subcuticle layers and in the animals' nerve chords. Furthermore, as determined by RT-PCR, Ascaris does not express the transcript of the neuronal mu receptor. Failure to demonstrate the expression of this opioid receptor, as well as the morphine-like tissue localization in Ascaris, suggests that the endogenous morphine is intended for secretion into the microenvironment.
Collapse
Affiliation(s)
- Y Goumon
- Neuroscience Research Institute, State University of New York, Old Westbury, NY 11568, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Briles DE, Hollingshead S, Brooks-Walter A, Nabors GS, Ferguson L, Schilling M, Gravenstein S, Braun P, King J, Swift A. The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine 2000; 18:1707-11. [PMID: 10689153 DOI: 10.1016/s0264-410x(99)00511-3] [Citation(s) in RCA: 104] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Pneumococcal proteins, alone, in combination with each other, or in combination with capsular polysaccharide-protein conjugates may be useful pneumococcal vaccine components. Four proteins with a potential for use in vaccines are PspA, pneumolysin, PsaA, and PspC. In a mouse model of carriage, PsaA and PspC were the most efficacious vaccine proteins. Of these, PsaA was the best at eliciting protection against carriage. However, a combination of PspA and pneumolysin may elicit stronger immunity to pulmonary infection and possibly sepsis than either protein alone. Recently, a phase one trial of a recombinant family 1 PspA was completed in man. PspA was observed to be safe and immunogenic. Injection of 0.1 ml of immune serum diluted to 1/400 was able to protect mice from fatal infection with S. pneumoniae. Under these conditions, pre-immune serum was not protective. The immune human serum protected mice from infections with pneumococci expressing either of the major PspA families (1 and 2) and both of the pneumococcal capsular types tested: 3 and 6.
Collapse
Affiliation(s)
- D E Briles
- Department of Microbiology, University of Alabama at Birmingham, 658 BBLB, 845 19th Street South, Birmingham, AL 35294, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|